FAKTOR OPTIONSSCHEIN - MERCK & CO. | Market Closed - Börse Stuttgart 15:51:55 2024-06-04 EDT | ||
| 8.34 EUR | -0.95% |
|
| Current month | -12.02% | ||
| 1 month | -8.08% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
MERCK & CO., INC.
Latest news about MERCK & CO., INC.
More news
| Date | Price | Change |
|---|---|---|
| 24-06-04 | 8.34 | -0.95% |
| 24-06-03 | 8.42 | -12.02% |
| 24-05-31 | 9.57 | +7.53% |
| 24-05-30 | 8.9 | -6.61% |
| 24-05-29 | 9.53 | +14.27% |
Delayed Quote Börse Stuttgart
Last update June 04, 2024 at 03:51 pm
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | MERCK & CO., INC. |
| Issuer | UBS |
| WKN | UM3T8L |
| ISIN | DE000UM3T8L3 |
| Date issued | 2024-03-28 |
| Strike | 154.1 $ |
| Maturity | Unlimited |
| Parity | 2.75 : 1 |
| Emission price | 10.57 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 10.41 € |
|---|---|
| Lowest since issue | 7.33 € |
| Spread | 0.6 € |
| Spread % | 6.07% |
Company Profile
Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows:
- sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.;
- sale of vaccines (18%);
- sale of animal health products (9.4%);
- other (2.9%).
Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
Consensus: Merck & Co., Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
128.7
USD
Average target price
142.2
USD
Spread / Average Target
+10.48%
- Stock Market
- Certificates
- Certificat
